Corrigendum: Small moleculemediated up-regulation of microRNA targeting a key cell death modulator BNIP3 improves cardiac function following ischemic injury (Scientific Reports (2016) DOI: 10.1038/srep23472);Small molecule-mediated up-regulation of microRNA targeting a key cell death modulator BNIP3 improves cardiac function following ischemic injury

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Lee, Se Yeon ^a   Lee, Seahyoung ^b   Choi, Eunhyun ^b   Ham, Onju ^a   Lee, Chang Youn ^c   Lee, Jiyun ^a   Seo, Hyang Hee ^a   Cha, Min Ji ^b   Mun, Bohyun ^d   Lee, Yunmi ^d   Yoon, Cheesoon ^b   Hwang, Ki Chul ^b  

^a Yonsei University College of Medicine   (South Korea)

^b Catholic Kwandong University   (South Korea)

^c Yonsei University   (South Korea)

^d Kwangwoon University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BENZAZEPINE DERIVATIVE; BNIP3 PROTEIN, MOUSE; INDOLE DERIVATIVE; KENPAULLONE; MEMBRANE PROTEIN; MICRORNA; MIRN182 MICRORNA, MOUSE; MITOCHONDRIAL PROTEIN; MOLECULAR LIBRARY;

ANIMAL; CARDIAC MUSCLE CELL; CELL CULTURE; CELL DEATH; CHEMISTRY; CYTOLOGY; DISEASE MODEL; DRUG EFFECTS; GENETICS; HEART FUNCTION TEST; HEART MUSCLE ISCHEMIA; MALE; MOLECULAR LIBRARY; PATHOPHYSIOLOGY; PHARMACOLOGY; RAT; SYNTHESIS; UPREGULATION;

ANIMALS; BENZAZEPINES; CELL DEATH; CELLS, CULTURED; DISEASE MODELS, ANIMAL; HEART FUNCTION TESTS; INDOLES; MALE; MEMBRANE PROTEINS; MICRORNAS; MITOCHONDRIAL PROTEINS; MYOCARDIAL ISCHEMIA; MYOCYTES, CARDIAC; RATS; SMALL MOLECULE LIBRARIES; UP-REGULATION;

EID: 84962252948     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep46973     Document Type: Erratum

References (45)

1. Kubasiak, L. A., Hernandez, O. M., Bishopric, N. H. & Webster, K. A. Hypoxia and acidosis activate cardiac myocyte death through the Bcl-2 family protein BNIP3. Proceedings of the National Academy of Sciences of the United States of America 99, 12825-12830, doi: 10. 1073/pnas. 202474099 (2002).
2. Bellot, G. et al. Hypoxia-induced autophagy is mediated through hypoxia-inducible factor induction of BNIP3 and BNIP3L via their BH3 domains. Molecular and cellular biology 29, 2570-2581, doi: 10. 1128/MCB. 00166-09 (2009).
3. Burton, T. R. & Gibson, S. B. The role of Bcl-2 family member BNIP3 in cell death and disease: NIPping at the heels of cell death. Cell death and differentiation 16, 515-523, doi: 10. 1038/cdd. 2008. 185 (2009).
4. Hamacher-Brady, A. et al. Response to myocardial ischemia/reperfusion injury involves Bnip3 and autophagy. Cell death and differentiation 14, 146-157, doi: 10. 1038/sj. cdd. 4401936 (2007).
5. Ma, X., Godar, R. J., Liu, H. & Diwan, A. Enhancing lysosome biogenesis attenuates BNIP3-induced cardiomyocyte death. Autophagy 8, 297-309, doi: 10. 4161/auto. 18658 (2012).
6. Diwan, A. et al. Inhibition of ischemic cardiomyocyte apoptosis through targeted ablation of Bnip3 restrains postinfarction remodeling in mice. J Clin Invest 117, 2825-2833, doi: 10. 1172/JCI32490 (2007).
7. Shepard, D. et al. Ischemic Heart Disease Worldwide, 1990 to 2013: Estimates From the Global Burden of Disease Study 2013. Circ Cardiovasc Qual Outcomes 8, 455-456, doi: 10. 1161/CIRCOUTCOMES. 115. 002007 (2015).
8. Wang, F. et al. miR-210 suppresses BNIP3 to protect against the apoptosis of neural progenitor cells. Stem Cell Res 11, 657-667, doi: 10. 1016/j. scr. 2013. 04. 005 (2013).
9. Li, R. et al. MicroRNA-145 protects cardiomyocytes against hydrogen peroxide (H(2)O(2))-induced apoptosis through targeting the mitochondria apoptotic pathway. Plos One 7, e44907, doi: 10. 1371/journal. pone. 0044907 (2012).
10. Chen, X. et al. MicroRNA145 targets BNIP3 and suppresses prostate cancer progression. Cancer Res 70, 2728-2738, doi: 10. 1158/0008-5472. CAN-09-3718 (2010).
11. Cui, S. Y., Wang, R. & Chen, L. B. MicroRNA-145: a potent tumour suppressor that regulates multiple cellular pathways. J Cell Mol Med 18, 1913-1926, doi: 10. 1111/jcmm. 12358 (2014).
12. Pecot, C. V., Calin, G. A., Coleman, R. L., Lopez-Berestein, G. & Sood, A. K. RNA interference in the clinic: challenges and future directions. Nat Rev Cancer 11, 59-67, doi: 10. 1038/nrc2966 (2011).
13. Plowright, A. T., Engkvist, O., Gill, A., Knerr, L. & Wang, Q. D. Heart regeneration: opportunities and challenges for drug discovery with novel chemical and therapeutic methods or agents. Angew Chem Int Ed Engl 53, 4056-4075, doi: 10. 1002/anie. 201307034 (2014).
14. Liu, R., Li, J., Teng, Z., Zhang, Z. & Xu, Y. Overexpressed microRNA-182 promotes proliferation and invasion in prostate cancer PC-3 cells by down-regulating N-myc downstream regulated gene 1 (NDRG1). Plos One 8, e68982, doi: 10. 1371/journal. pone. 0068982 (2013).
15. Wang, Y. Q., Guo, R. D., Guo, R. M., Sheng, W. & Yin, L. R. MicroRNA-182 promotes cell growth, invasion, and chemoresistance by targeting programmed cell death 4 (PDCD4) in human ovarian carcinomas. J Cell Biochem 114, 1464-1473, doi: 10. 1002/jcb. 24488 (2013).
16. Yang, M. H. et al. microRNA-182 targets special AT-rich sequence-binding protein 2 to promote colorectal cancer proliferation and metastasis. J Transl Med 12, 109, doi: 10. 1186/1479-5876-12-109 (2014).
17. Sachdeva, M. et al. MicroRNA-182 drives metastasis of primary sarcomas by targeting multiple genes. J Clin Invest 124, 4305-4319, doi: 10. 1172/JCI77116 (2014).
18. Wei, Q., Lei, R. & Hu, G. Roles of miR-182 in sensory organ development and cancer. Thorac Cancer 6, 2-9, doi: 10. 1111/1759-7714. 12164 (2015).
19. Kim, K. M. et al. miR-182 is a negative regulator of osteoblast proliferation, differentiation, and skeletogenesis through targeting FoxO1. J Bone Miner Res 27, 1669-1679, doi: 10. 1002/jbmr. 1604 (2012).
20. Meng, Z. et al. [MicroRNA-182 modulates high glucose-induced cardiomyocyte hypertrophy via targeting Rac1]. Zhonghua Xin Xue Guan Bing Za Zhi 43, 619-624 (2015).
21. Grimson, A. et al. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell 27, 91-105, doi: 10. 1016/j. molcel. 2007. 06. 017 (2007).
22. Kozomara, A. & Griffiths-Jones, S. miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res 42, D68-73, doi: 10. 1093/nar/gkt1181 (2014).
23. Landes, T. et al. The BH3-only Bnip3 binds to the dynamin Opa1 to promote mitochondrial fragmentation and apoptosis by distinct mechanisms. EMBO Rep 11, 459-465, doi: 10. 1038/embor. 2010. 50 (2010).
24. Bader, A. G. miR-34-a microRNA replacement therapy is headed to the clinic. Frontiers in genetics 3, 120, doi: 10. 3389/ fgene. 2012. 00120 (2012).
25. Ibrahim, A. F. et al. MicroRNA replacement therapy for miR-145 and miR-33a is efficacious in a model of colon carcinoma. Cancer Res 71, 5214-5224, doi: 10. 1158/0008-5472. CAN-10-4645 (2011).
26. Deiters, A. Small molecule modifiers of the microRNA and RNA interference pathway. AAPS J 12, 51-60, doi: 10. 1208/s12248-009-9159-3 (2010).
27. Young, D. D., Connelly, C. M., Grohmann, C. & Deiters, A. Small molecule modifiers of microRNA miR-122 function for the treatment of hepatitis C virus infection and hepatocellular carcinoma. J Am Chem Soc 132, 7976-7981, doi: 10. 1021/ja910275u (2010).
28. Gumireddy, K. et al. Small-molecule inhibitors of microrna miR-21 function. Angew Chem Int Ed Engl 47, 7482-7484, doi: 10. 1002/ anie. 200801555 (2008).
29. Xiao, Z. et al. A small-molecule modulator of the tumor-suppressor miR34a inhibits the growth of hepatocellular carcinoma. Cancer Res 74, 6236-6247, doi: 10. 1158/0008-5472. CAN-14-0855 (2014).
30. Watashi, K., Yeung, M. L., Starost, M. F., Hosmane, R. S. & Jeang, K. T. Identification of small molecules that suppress microRNA function and reverse tumorigenesis. J Biol Chem 285, 24707-24716, doi: 10. 1074/jbc. M109. 062976 (2010).
31. Velagapudi, S. P., Gallo, S. M. & Disney, M. D. Sequence-based design of bioactive small molecules that target precursor microRNAs. Nat Chem Biol 10, 291-297, doi: 10. 1038/nchembio. 1452 (2014).
32. Circu, M. L. & Aw, T. Y. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med 48, 749-762, doi: 10. 1016/j. freeradbiomed. 2009. 12. 022 (2010).
33. Duffey, M. O. et al. Discovery of a potent and orally bioavailable benzolactam-derived inhibitor of Polo-like kinase 1 (MLN0905). J Med Chem 55, 197-208, doi: 10. 1021/jm2011172 (2012).
34. Schultz, C. et al. Paullones, a series of cyclin-dependent kinase inhibitors: synthesis, evaluation of CDK1/cyclin B inhibition, and in vitro antitumor activity. J Med Chem 42, 2909-2919, doi: 10. 1021/jm9900570 (1999).
35. Meijer, L., Flajolet, M. & Greengard, P. Pharmacological inhibitors of glycogen synthase kinase 3. Trends Pharmacol Sci 25, 471-480, doi: 10. 1016/j. tips. 2004. 07. 006 (2004).
36. Liu, C. et al. Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 108, 837-847 (2002).
37. Chiang, C. H., Hou, M. F. & Hung, W. C. Up-regulation of miR-182 by beta-catenin in breast cancer increases tumorigenicity and invasiveness by targeting the matrix metalloproteinase inhibitor RECK. Biochim Biophys Acta 1830, 3067-3076, doi: 10. 1016/j. bbagen. 2013. 01. 009 (2013).
38. Handeli, S. & Simon, J. A. A small-molecule inhibitor of Tcf/beta-catenin signaling down-regulates PPARgamma and PPARdelta activities. Mol Cancer Ther 7, 521-529, doi: 10. 1158/1535-7163. MCT-07-2063 (2008).
39. Li, Y. et al. Hypoxia-inducible miR-182 enhances HIF1alpha signaling via targeting PHD2 and FIH1 in prostate cancer. Sci Rep 5, 12495, doi: 10. 1038/srep12495 (2015).
40. Schnitzer, S. E., Schmid, T., Zhou, J., Eisenbrand, G. & Brune, B. Inhibition of GSK3beta by indirubins restores HIF-1alpha accumulation under prolonged periods of hypoxia/anoxia. FEBS Lett 579, 529-533, doi: 10. 1016/j. febslet. 2004. 12. 023 (2005).
41. Stittrich, A. B. et al. The microRNA miR-182 is induced by IL-2 and promotes clonal expansion of activated helper T lymphocytes. Nat Immunol 11, 1057-1062, doi: 10. 1038/ni. 1945 (2010).
42. Sheikh, F. et al. Mouse and computational models link Mlc2v dephosphorylation to altered myosin kinetics in early cardiac disease. J Clin Invest 122, 1209-1221, doi: 10. 1172/JCI61134 (2012).
43. Sheikh, F., Lyon, R. C. & Chen, J. Getting the skinny on thick filament regulation in cardiac muscle biology and disease. Trends Cardiovasc Med 24, 133-141, doi: 10. 1016/j. tcm. 2013. 07. 004 (2014).
44. Jeyaraman, M. M. & Srisakuldee, W., Nickel, B. E. & Kardami, E. Connexin43 phosphorylation and cytoprotection in the heart. Biochimica et biophysica acta 1818, 2009-2013, doi: 10. 1016/j. bbamem. 2011. 06. 023 (2012).
45. Liu, X. et al. MicroRNA-31 regulated by the extracellular regulated kinase is involved in vascular smooth muscle cell growth via large tumor suppressor homolog 2. J Biol Chem 286, 42371-42380, doi: 10. 1074/jbc. M111. 261065 (2011).